Austar Lifesciences Ltd
Company Profile
Business description
Austar Lifesciences Ltd is a China-based company engaged in providing engineering solutions to pharmaceutical manufacturers and research institutes. The business activity of the group is operated through Liquid and Bioprocess Systems; Clean Room and Automation Control and Monitoring Systems; Powder and Solid Systems; Good Manufacturing Practice (GMP) Compliance Services; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment segments. It derives the majority of revenue from the Liquid and Bioprocess System segment which is involved in providing solutions in pharmaceutical and water systems to treat water. The geographical business presence of the firm is seen across China and in other countries.
Contact
No. 1018, Changning Road
Rooms 2010-2013, 20th Floor
Changning District
Shanghai
CHNT: +86 4008121586
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
1,492
Stocks News & Analysis
stocks
2 undervalued ASX shares report
stocks
Turmoil at WiseTech
video
What does the RBA rate cut mean for investors?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,503.20 | 56.90 | -0.66% |
CAC 40 | 8,090.99 | 63.52 | -0.78% |
DAX 40 | 22,425.93 | 138.37 | 0.62% |
Dow JONES (US) | 43,461.21 | 33.19 | 0.08% |
FTSE 100 | 8,658.98 | 0.39 | -0.00% |
HKSE | 23,184.55 | 157.06 | -0.67% |
NASDAQ | 19,286.93 | 237.08 | -1.21% |
Nikkei 225 | 38,364.37 | 412.57 | -1.06% |
NZX 50 Index | 12,363.34 | 168.38 | -1.34% |
S&P 500 | 5,983.25 | 29.88 | -0.50% |
S&P/ASX 200 | 8,255.70 | 52.50 | -0.63% |
SSE Composite Index | 3,368.52 | 4.50 | -0.13% |